Denali Therapeutics Inc.
DNLI · Healthcare · $3.3B
$20.68+0.05%
Price
$25.83
$21.00
Jul 2, 26Oct 1, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$12M+239.3%
6/'26 vs prev quarter
Company Health
Market Cap$3.3B
Operating Margin-15058.2%
Cash on Hand$710M21.7% of market cap
Free Cash Flow$-571M-17.4% of market cap
Among 327 Biotechnology peers
LowMedianHigh
PSR910.3xmedian 11.4xPBR3.9xmedian 2.0xROE-61.2%median -54.5%
